West Pharma (WST) Reports In-Line Q3 EPS; Narrows EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Wells Fargo Upgrades West Pharmaceutical (WST) to Outperform
October 28, 2016 7:11 AM EDTWells Fargo upgraded West Pharmaceutical (NYSE: WST) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on West Pharmaceutical click here. For more ratings news on West Pharmaceutical click here.
Shares of West Pharmaceutical closed at $72.42 yesterday.
... More